SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-15-055948
Filing Date
2015-09-22
Accepted
2015-09-22 17:00:12
Documents
3
Period of Report
2015-09-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v420732_8k.htm 8-K 17578
2 EXHIBIT 99.1 v420732_ex99-1.htm EX-99.1 12265
3 GRAPHIC tex99-1logo.jpg GRAPHIC 16930
  Complete submission text file 0001144204-15-055948.txt   54638
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20713 | Film No.: 151119792
SIC: 2836 Biological Products, (No Diagnostic Substances)